Anhui Provincial Cancer Hospital
Clinical trials sponsored by Anhui Provincial Cancer Hospital, explained in plain language.
-
New drug combo shows promise for tough breast cancer in early trial
Disease control Not yet recruitingThis study tests a new combination of drugs (iparomlimab and tuvonralimab with chemotherapy) given before surgery to 30 people with a common type of breast cancer called HR+/HER2-. The goal is to see if the treatment can eliminate all cancer cells in the breast and lymph nodes by…
Phase: PHASE2 • Sponsor: Anhui Provincial Cancer Hospital • Aim: Disease control
Last updated May 17, 2026 04:37 UTC
-
New drug cocktail targets stubborn stomach cancer
Disease control Not yet recruitingThis study is testing a combination of two drugs, TAS-102 and apatinib, as a third-line treatment for people with advanced gastric cancer that has not responded to earlier therapies. About 30 participants will receive this drug combo to see if it can shrink tumors or slow disease…
Phase: NA • Sponsor: Anhui Provincial Cancer Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug cocktail aims to shrink triple-positive breast tumors before surgery
Disease control Not yet recruitingThis study tests a combination of four drugs (trastuzumab, pertuzumab, palbociclib, and exemestane) given before surgery to people with early or locally advanced triple-positive breast cancer. The goal is to see if this treatment can eliminate all signs of cancer in the breast an…
Phase: PHASE2 • Sponsor: Anhui Provincial Cancer Hospital • Aim: Disease control
Last updated May 14, 2026 12:04 UTC